The dual immune landscape of homologous recombination-deficient tumors: mechanisms and therapeutic implications.

Yang Y, Yin Y, Rong S, Qian Y, Li D, Zhang Y, Wang X

Open source

DOI
10.1007/s10555-026-10380-9
Published
2026 Sep 23
Container
Cancer metastasis reviews
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s10555-026-10380-9,
  title = {The dual immune landscape of homologous recombination-deficient tumors: mechanisms and therapeutic implications.},
  author = {Yang Y and Yin Y and Rong S and Qian Y and Li D and Zhang Y and Wang X},
  year = {2026},
  journal = {Cancer metastasis reviews},
  doi = {10.1007/s10555-026-10380-9},
  url = {https://doi.org/10.1007/s10555-026-10380-9}
}

RIS

TY  - JOUR
TI  - The dual immune landscape of homologous recombination-deficient tumors: mechanisms and therapeutic implications.
AU  - Yang Y
AU  - Yin Y
AU  - Rong S
AU  - Qian Y
AU  - Li D
AU  - Zhang Y
AU  - Wang X
PY  - 2026
JO  - Cancer metastasis reviews
DO  - 10.1007/s10555-026-10380-9
UR  - https://doi.org/10.1007/s10555-026-10380-9
ER  - 

APA

Y, Y., Y, Y., S, R., Y, Q., D, L., Y, Z., & X, W. (2026). The dual immune landscape of homologous recombination-deficient tumors: mechanisms and therapeutic implications.. Cancer metastasis reviews. https://doi.org/10.1007/s10555-026-10380-9

Source records